These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36220341)
1. Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on disease. Maggi L; Bello L; Bonanno S; Govoni A; Caponnetto C; Passamano L; Grandis M; Trojsi F; Cerri F; Gardani A; Ferraro M; Gadaleta G; Zangaro V; Caumo L; Maioli M; Tanel R; Saccani E; Meneri M; Vacchiano V; Ricci G; Sorarù G; D'Errico E; Bortolani S; Pavesi G; Gellera C; Zanin R; Corti S; Silvestrini M; Politano L; Schenone A; Previtali SC; Berardinelli A; Turri M; Verriello L; Coccia M; Mantegazza R; Liguori R; Filosto M; Marrosu G; Tiziano FD; Siciliano G; Simone IL; Mongini T; Comi G; Pegoraro E J Neurol Neurosurg Psychiatry; 2022 Dec; 93(12):1253-1261. PubMed ID: 36220341 [TBL] [Abstract][Full Text] [Related]
2. Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy. Lusakowska A; Jedrzejowska M; Kaminska A; Janiszewska K; Grochowski P; Zimowski J; Sierdzinski J; Kostera-Pruszczyk A Orphanet J Rare Dis; 2021 Mar; 16(1):150. PubMed ID: 33761963 [TBL] [Abstract][Full Text] [Related]
3. Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3. Maggi L; Bello L; Bonanno S; Govoni A; Caponnetto C; Passamano L; Grandis M; Trojsi F; Cerri F; Ferraro M; Bozzoni V; Caumo L; Piras R; Tanel R; Saccani E; Meneri M; Vacchiano V; Ricci G; Soraru' G; D'Errico E; Tramacere I; Bortolani S; Pavesi G; Zanin R; Silvestrini M; Politano L; Schenone A; Previtali SC; Berardinelli A; Turri M; Verriello L; Coccia M; Mantegazza R; Liguori R; Filosto M; Marrosu G; Siciliano G; Simone IL; Mongini T; Comi G; Pegoraro E J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1166-1174. PubMed ID: 32917822 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Symptomatic Spinal Muscular Atrophy with Nusinersen: A Prospective Longitudinal Study on Scoliosis Progression. Ip HNH; Yu MKL; Wong WHS; Liu A; Kwan KYH; Chan SHS J Neuromuscul Dis; 2024; 11(2):349-359. PubMed ID: 38363614 [TBL] [Abstract][Full Text] [Related]
5. Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen. Bonanno S; Zanin R; Bello L; Tramacere I; Bozzoni V; Caumo L; Ferraro M; Bortolani S; Sorarù G; Silvestrini M; Vacchiano V; Turri M; Tanel R; Liguori R; Coccia M; Mantegazza RE; Mongini T; Pegoraro E; Maggi L J Neurol; 2022 Jun; 269(6):3264-3275. PubMed ID: 34978620 [TBL] [Abstract][Full Text] [Related]
6. Respiratory function in a large cohort of treatment-naïve adult spinal muscular atrophy patients: a cross-sectional study. Vicino A; Bello L; Bonanno S; Govoni A; Cerri F; Ferraro M; Capece G; Gadaleta G; Meneri M; Vacchiano V; Ricci G; D'Errico E; Tramacere I; Banfi P; Bortolani S; Zanin R; Maioli MA; Silvestrini M; Previtali SC; Berardinelli A; Turri M; Coccia M; Mantegazza R; Liguori R; Filosto M; Siciliano G; Simone IL; Mongini T; Comi G; Pegoraro E; Maggi L Neuromuscul Disord; 2023 Dec; 33(12):911-916. PubMed ID: 37945485 [TBL] [Abstract][Full Text] [Related]
7. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study. Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243 [TBL] [Abstract][Full Text] [Related]
8. Deletion analysis of SMN1 and NAIP genes in Southern Chinese children with spinal muscular atrophy. Liang YH; Chen XL; Yu ZS; Chen CY; Bi S; Mao LG; Zhou BL; Zhang XN J Zhejiang Univ Sci B; 2009 Jan; 10(1):29-34. PubMed ID: 19198020 [TBL] [Abstract][Full Text] [Related]
9. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4. Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869 [TBL] [Abstract][Full Text] [Related]
10. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Wolfe A; Stimpson G; Ramsey D; Coratti G; Dunaway Young S; Mayhew A; Pane M; Rohwer A; Muni Lofra R; Duong T; O'Reilly E; Milev E; Civitello M; Sansone VA; D'Amico A; Bertini E; Messina S; Bruno C; Albamonte E; Mazzone E; Main M; Montes J; Glanzman AM; Zolkipli-Cunningham Z; Pasternak A; Marini-Bettolo C; Day JW; Darras BT; De Vivo DC; Baranello G; Scoto M; Finkel RS; Mercuri E; Muntoni F; J Neuromuscul Dis; 2024; 11(3):665-677. PubMed ID: 38427497 [TBL] [Abstract][Full Text] [Related]
11. Drug treatment for spinal muscular atrophy types II and III. Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF Cochrane Database Syst Rev; 2020 Jan; 1(1):CD006282. PubMed ID: 32006461 [TBL] [Abstract][Full Text] [Related]
12. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene. Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550 [TBL] [Abstract][Full Text] [Related]
13. Nociceptive pain in adult patients with 5q-spinal muscular atrophy type 3: a cross-sectional clinical study. Sagerer E; Wirner C; Schoser B; Wenninger S J Neurol; 2023 Jan; 270(1):250-261. PubMed ID: 36036285 [TBL] [Abstract][Full Text] [Related]
14. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease). Salort-Campana E; Quijano-Roy S Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593 [TBL] [Abstract][Full Text] [Related]
15. Sex Difference in Spinal Muscular Atrophy Patients - are Males More Vulnerable? Sun J; Harrington MA; Porter B; J Neuromuscul Dis; 2023; 10(5):847-867. PubMed ID: 37393514 [TBL] [Abstract][Full Text] [Related]
16. Effect of Discontinuation of Nusinersen Treatment in Long-Standing SMA3. Hiebeler M; Abicht A; Reilich P; Walter MC J Neuromuscul Dis; 2021; 8(4):537-542. PubMed ID: 33682724 [TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina. Medrano S; Monges S; Gravina LP; Alías L; Mozzoni J; Aráoz HV; Bernal S; Moresco A; Chertkoff L; Tizzano E Eur J Paediatr Neurol; 2016 Nov; 20(6):910-917. PubMed ID: 27510309 [TBL] [Abstract][Full Text] [Related]
18. Spinal muscular atrophy in an upper-middle-income nation before the advent of reimbursed disease-modifying therapies. Sakpichaisakul K; Katanyuwong K; Intusoma U; Paprad T; Suwanpakdee P; Khongkhatithum C; Sanmaneechai O BMJ Paediatr Open; 2024 Aug; 8(1):. PubMed ID: 39216878 [TBL] [Abstract][Full Text] [Related]
19. Longer-term follow-up of nusinersen efficacy and safety in adult patients with spinal muscular atrophy types 2 and 3. Fainmesser Y; Drory VE; Ben-Shushan S; Lavon A; Spector L; Abramovich B; Abraham A Neuromuscul Disord; 2022 Jun; 32(6):451-459. PubMed ID: 35527201 [TBL] [Abstract][Full Text] [Related]
20. Secondary outcomes of scoliosis surgery in disease-modifying treatment-naïve patients with spinal muscular atrophy type 2 and nonambulant type 3. Brusa C; Baranello G; Ridout D; de Graaf J; Manzur AY; Munot P; Sarkozy A; Main M; Milev E; Iodice M; Ramsey D; Tucker S; Ember T; Nadarajah R; Muntoni F; Scoto M Muscle Nerve; 2024 Nov; 70(5):1000-1009. PubMed ID: 39233378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]